| Closed |
S1619 |
Neoadjuvant Cisplatin-Pemetrexed with Atezolizumab |
11/3/2017 |
5/1/2020 |
100% |
|
|
| Closed |
SWOG-8704 |
Neoadjuvant Methotrexate, Cisplatin and Vinblastine (MCV) Followed by Concomitant Cisplatin/Radiotherapy for Unresectable Localized Bladder Cancer Patients |
9/1/1987 |
8/15/1991 |
90% |
|
Published
|
| Closed |
S0012 |
NEOADJUVANT: Standard AC vs. Weekly A and Daily Oral C + G-CSF |
5/1/2001 |
12/1/2005 |
100% |
|
Published
|
| Closed |
S0925 |
New Hormone-Sensitive Metastatic PCa, Androgen Deprivation +/- IMC-A12, Ph II |
12/15/2010 |
12/1/2012 |
100% |
|
Published
|
| Closed |
S0204 |
Newly Diagnosed Multiple Myeloma Tandem Transplant |
6/15/2002 |
10/15/2005 |
100% |
|
Published
|
| Closed |
SWOG-7204/7205 |
Non-Hodgkin's Lymphoma CHOP vs. HOP Combination Chemotherapy for Remission Induction and COP vs. OAP Combination Chemotherapy for Maintenance |
4/17/1972 |
9/10/1974 |
|
|
Published
|
| Closed |
SWOG-7433 |
Non-Hodgkin's Lymphomas (Stages I, IE, II, and IIE) |
12/27/1974 |
1/29/1981 |
|
|
Published
|
| Closed |
S0108 |
NON-HODGKIN'S: Bevacizumab For Relapsed Aggressive NHL |
4/15/2001 |
12/1/2004 |
87% |
|
Published
|
| Closed |
S0313 |
NON-HODGKIN'S: CHOP + IF RT followed by Yttrium-90 Ibritumomab Tiuxetan |
2/1/2004 |
12/15/2008 |
77% |
|
Published
|
| Closed |
S0349 |
NON-HODGKIN'S: CHOP plus G3139 for Adv Stage Large B-cell of Low and Low-Int IPI Risk |
3/1/2004 |
5/15/2006 |
10% |
|
|
| Closed |
S0014 |
NON-HODGKIN'S: CHOP with concurrent rituximab plus IFR |
4/1/2000 |
1/15/2002 |
100% |
|
Published
|
| Closed |
S9704 |
NON-HODGKIN'S: CHOP x 8 vs. CHOP x 6 followed by TBI/VP-6/cylophosphamide or SWOG BCV with stem cell rescue |
9/15/1997 |
12/15/2007 |
100% |
|
Published
|
| Closed |
S0016 |
NON-HODGKIN'S: CHOP/rituximab vs. CHOP/tositumomab |
3/1/2001 |
10/2/2008 |
100% |
|
Published
|
| Closed |
SWOG-9438 |
NON-HODGKIN'S: Debulking salvage chemo adn stem cell harvest -> TBI/cyclophosphamide -> PBSCT and randmization to IL-2 or obs. |
5/15/1995 |
7/1/2004 |
98% |
|
Published
|
| Closed |
S0019 |
NON-HODGKIN'S: ICE +/- Rituxan for Relapsed/Refractory CD20+ B-Cell NHL |
10/15/2000 |
12/15/2001 |
2% |
|
Published
|
| Closed |
S0515 |
NON-HODGKIN'S: R-CHOP + Bevacizumab for Adv Stage Diffuse Large B-cell NHL |
6/15/2005 |
9/15/2008 |
100% |
|
Published
|
| Closed |
S0801 |
NON-HODGKIN: Bexxar + CHOP-Rituximab for Advanced Follicular NHL |
4/1/2009 |
12/15/2010 |
100% |
|
|
| Closed |
S0350 |
NON-HODGKIN: PEGS treatment for Peripheral T-Cell NHL |
9/15/2005 |
12/1/2010 |
100% |
|
Published
|
| Closed |
S0520 |
NON-HODGKIN: PXD101 Therapy for B-Cell Lymphoma |
1/1/2006 |
5/1/2009 |
55% |
|
Published
|
| Closed |
S0433 |
NON-HODGKIN: R-CHOP + Bexxar for Advanced Stage Diffuse Large B-Cell Lymphoma |
11/1/2005 |
|
100% |
|
Published
|
